Sigma Healthcare (ASX:SIG)
report NPAT up 133.6 per cent to $29.1 million.
Reported EBITDA of $94.2 million for FY21, up 289.2 per cent on the prior year, with Underlying EBITDA of $81.1 million up 39.2 per cent, which is slightly ahead of the guidance provided on 8 February 2021.
Sigma CEO and Managing Director Mark Hooper commented: “This is a milestone result.
The Board has declared a dividend of one cent per share fully franked.
Shares in Sigma Healthcare (ASX:SIG)
are trading 3.4 per cent higher at 69 cents.